Clinical Trial Update: USTekinumab in Fistulising Perianal Crohn's Disease (USTAP) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for ustekinumab in fistulising perianal Crohn's disease; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn's Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING